Below are the most recent publications written about "Huntington Disease" by people in Profiles.
-
Skeens A, Siriwardhana C, Massinople SE, Wunder MM, Ellis ZL, Keith KM, Girman T, Frey SL, Legleiter J. The polyglutamine domain is the primary driver of seeding in huntingtin aggregation. PLoS One. 2024; 19(3):e0298323.
-
Ortiz NJ, M?ndez M, Avil?s G, Rom?n C, Narv?ez-Cordero P, Vald?s E, Cabrera-R?os M, Isaza CE. A Cost Model for Neurological Diseases in Puerto Rico: Parkinson's Disease, Alzheimer's Disease and Huntington's Disease. P R Health Sci J. 2023 06; 42(2):146-151.
-
Hung CY, Zhu C, Kittur FS, He M, Arning E, Zhang J, Johnson AJ, Jawa GS, Thomas MD, Ding TT, Xie J. A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR. Cell Mol Life Sci. 2022 Oct 17; 79(11):553.
-
Groover SE, Adegbuyiro A, Fan CK, Hodges BL, Beasley M, Taylor K, Stonebraker AR, Siriwardhana C, Legleiter J. Macromolecular crowding in solution alters huntingtin interaction and aggregation at interfaces. Colloids Surf B Biointerfaces. 2021 Oct; 206:111969.
-
Adegbuyiro A, Sedighi F, Jain P, Pinti MV, Siriwardhana C, Hollander JM, Legleiter J. Mitochondrial membranes modify mutant huntingtin aggregation. Biochim Biophys Acta Biomembr. 2021 10 01; 1863(10):183663.
-
Friedman A, Hueske E, Drammis SM, Toro Arana SE, Nelson ED, Carter CW, Delcasso S, Rodriguez RX, Lutwak H, DiMarco KS, Zhang Q, Rakocevic LI, Hu D, Xiong JK, Zhao J, Gibb LG, Yoshida T, Siciliano CA, Diefenbach TJ, Ramakrishnan C, Deisseroth K, Graybiel AM. Striosomes Mediate Value-Based Learning Vulnerable in Age and a Huntington's Disease Model. Cell. 2020 11 12; 183(4):918-934.e49.
-
Holtbernd F, Tang CC, Feigin A, Dhawan V, Ghilardi MF, Paulsen JS, Guttman M, Eidelberg D. Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease. PLoS One. 2016; 11(5):e0154742.
-
Polyzos A, Holt A, Brown C, Cosme C, Wipf P, Gomez-Marin A, Castro MR, Ayala-Pe?a S, McMurray CT. Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes. Hum Mol Genet. 2016 05 01; 25(9):1792-802.
-
Budworth H, Harris FR, Williams P, Lee DY, Holt A, Pahnke J, Szczesny B, Acevedo-Torres K, Ayala-Pe?a S, McMurray CT. Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease. PLoS Genet. 2015 Aug; 11(8):e1005267.
-
Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Transl Psychiatry. 2013 Dec 03; 3:e332.